Sebastien IRIGARAY

Person

  • Mulhouse, FR

Patents Grantslast 30 patents

Patents Applicationslast 30 patents

  • Information Patent Application

    THERAPEUTIC FUSION PROTEINS

    • Publication number 20230308835
    • Publication date Sep 28, 2023
    • Novartis AG
    • Sebastien IRIGARAY
    • H04 - ELECTRIC COMMUNICATION TECHNIQUE
  • Information Patent Application

    ENGINEERED HETERODIMERIC PROTEINS

    • Publication number 20230295291
    • Publication date Sep 21, 2023
    • Novartis AG
    • Regis CEBE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    THERAPEUTIC FUSION PROTEINS

    • Publication number 20230265160
    • Publication date Aug 24, 2023
    • Novartis AG
    • Sebastien IRIGARAY
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    ENGINEERED IMMUNOGLOBULINS

    • Publication number 20230242647
    • Publication date Aug 3, 2023
    • Novartis AG
    • John BLANKENSHIP
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    THERAPEUTIC FUSION PROTEINS

    • Publication number 20230220048
    • Publication date Jul 13, 2023
    • Novartis AG
    • Sebastien IRIGARAY
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    IMMUNOGLOBULIN VARIANTS

    • Publication number 20230167193
    • Publication date Jun 1, 2023
    • Novartis AG
    • John BLANKENSHIP
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ENGINEERED HETERODIMERIC PROTEINS

    • Publication number 20190382475
    • Publication date Dec 19, 2019
    • Novartis AG
    • Regis CEBE
    • C07 - ORGANIC CHEMISTRY